CBIO

Crescent Biopharma, Inc. Common Stock

35 hedge funds and large institutions have $14.3M invested in Crescent Biopharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
35
Holders Change
-2
Holders Change %
-5.41%
% of All Funds
0.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
6
Closed
5
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
-$31K